1 of 4
FEATURED COMPANIES
- 10X Genomics Inc.
- Bio-Rad Laboratories Inc.
- Eppendorf AG
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- QIAGEN N.V.
- MORE
According to a study conducted by the publisher, the global genomics market is expected to generate a revenue of $68.0 billion by 2030, increasing from $18.2 billion in 2019, progressing at a 12.7% CAGR during the forecast period (2020–2030).
The market is growing due to the increasing government initiatives and support, rising requirement for personalized medicine, and reduction in the cost of sequencing services. In terms of solution, the market is categorized into services, consumables, and instruments, among which, the consumables category dominated the market in 2019.
This can be attributed to the rising number of samples that are being processed at labs, research centers, and several other end-use settings. In addition to this, the growing number of research projects are also resulting in the rising demand for consumables. On the basis of application, the genomics market is categorized into diagnostics, agriculture and animal research, precision medicine, and drug discovery & development. Among which, the diagnostics category held the major share of the market in 2019, owing to the rising research projects related to genetic diseases, including cancer.
When technology is taken into consideration, the genomics market is classified into microarray, polymerase chain reaction, and sequencing, out of which, the sequencing classification is predicted to witness the highest CAGR during the forecast period. The demand for this technology is growing rapidly, owing to its lowering cost. As per the National Human Genome research Institute, the cost of genome sequencing was about $10,000 in the mid-2011, which decreased considerably to $1,000 in 2018. This is expected to drive the adoption of sequencing, thereby leading to the growth of the market.
North America accounted for the largest share of the market in the past, which is because of the various ongoing genomics research projects, presence of major players, and increasing investments in the industry by both government and private organizations. The Asia-Pacific region is predicted to register the highest CAGR during the forecast period, as the number of research activities in the field to genomics is growing in countries including Japan, India, and China. Both public and private organizations are providing funding for innovations in genome research.
In conclusion, the market is being driven by increasing need for personalized medicine and rising support and initiatives by governments across the globe.
The market is growing due to the increasing government initiatives and support, rising requirement for personalized medicine, and reduction in the cost of sequencing services. In terms of solution, the market is categorized into services, consumables, and instruments, among which, the consumables category dominated the market in 2019.
This can be attributed to the rising number of samples that are being processed at labs, research centers, and several other end-use settings. In addition to this, the growing number of research projects are also resulting in the rising demand for consumables. On the basis of application, the genomics market is categorized into diagnostics, agriculture and animal research, precision medicine, and drug discovery & development. Among which, the diagnostics category held the major share of the market in 2019, owing to the rising research projects related to genetic diseases, including cancer.
When technology is taken into consideration, the genomics market is classified into microarray, polymerase chain reaction, and sequencing, out of which, the sequencing classification is predicted to witness the highest CAGR during the forecast period. The demand for this technology is growing rapidly, owing to its lowering cost. As per the National Human Genome research Institute, the cost of genome sequencing was about $10,000 in the mid-2011, which decreased considerably to $1,000 in 2018. This is expected to drive the adoption of sequencing, thereby leading to the growth of the market.
North America accounted for the largest share of the market in the past, which is because of the various ongoing genomics research projects, presence of major players, and increasing investments in the industry by both government and private organizations. The Asia-Pacific region is predicted to register the highest CAGR during the forecast period, as the number of research activities in the field to genomics is growing in countries including Japan, India, and China. Both public and private organizations are providing funding for innovations in genome research.
In conclusion, the market is being driven by increasing need for personalized medicine and rising support and initiatives by governments across the globe.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- 10X Genomics Inc.
- Bio-Rad Laboratories Inc.
- Eppendorf AG
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- QIAGEN N.V.
- MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Solution
1.3.2 Market Segmentation by Technology
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.2 Primary Research
2.2.1 Split of Primary Research Information
2.2.2 Breakdown of Primary Research Respondents
2.2.2.1 By industry participant
2.2.2.2 By company type
2.2.3 Breakdown of Primary Research by Company and Designation
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 Data Triangulation
2.6 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Solution
4.1.1.1 Consumables
4.1.1.2 Instruments
4.1.1.3 Services
4.1.2 By Technology
4.1.2.1 PCR
4.1.2.2 Sequencing
4.1.2.3 Microarray
4.1.2.4 Others
4.1.3 By Application
4.1.3.1 Diagnostics
4.1.3.2 Drug discovery and development
4.1.3.3 Precision medicine
4.1.3.4 Agriculture and animal research
4.1.3.5 Others
4.1.4 By End User
4.1.4.1 Research centers and academic institutes
4.1.4.2 Hospitals and clinics
4.1.4.3 Pharmaceutical and biotechnology companies
4.1.4.4 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing number of acquisitions
4.2.1.2 Growing partnerships among market players
4.2.2 Drivers
4.2.2.1 Rising government support and initiatives
4.2.2.2 Reducing cost of sequencing services
4.2.2.3 Growing demand for personalized medicines
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Data privacy concerns
4.2.3.2 High data storage requirements
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Potential to cure previously incurable diseases
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Buyers
4.4.2 Bargaining Power of Suppliers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes
Chapter 5. Global Market Size and Forecast
5.1 By Solution
5.2 By Technology
5.3 By Application
5.4 By End User
5.5 By Region
Chapter 6. North America Market Size and Forecast
6.1 Overview
6.2 By Solution
6.3 By Technology
6.4 By Application
6.5 By End User
6.6 By Country
6.6.1 U.S. Market Size and Forecast
6.6.1.1 By solution
6.6.1.2 By technology
6.6.2 Canada Market Size and Forecast
6.6.2.1 By solution
6.6.2.2 By technology
Chapter 7. Europe Market Size and Forecast
7.1 Overview
7.2 By Solution
7.3 By Technology
7.4 By Application
7.5 By End User
7.6 By Country
7.6.1 U.K. Market Size and Forecast
7.6.1.1 By solution
7.6.1.2 By technology
7.6.2 Germany Market Size and Forecast
7.6.2.1 By solution
7.6.2.2 By technology
7.6.3 France Market Size and Forecast
7.6.3.1 By solution
7.6.3.2 By technology
7.6.4 Italy Market Size and Forecast
7.6.4.1 By solution
7.6.4.2 By technology
7.6.5 Spain Market Size and Forecast
7.6.5.1 By solution
7.6.5.2 By technology
Chapter 8. APAC Market Size and Forecast
8.1 Overview
8.2 By Solution
8.3 By Technology
8.4 By Application
8.5 By End User
8.6 By Country
8.6.1 China Market Size and Forecast
8.6.1.1 By solution
8.6.1.2 By technology
8.6.2 Japan Market Size and Forecast
8.6.2.1 By solution
8.6.2.2 By technology
8.6.3 India Market Size and Forecast
8.6.3.1 By solution
8.6.3.2 By technology
Chapter 9. LATAM Market Size and Forecast
9.1 Overview
9.2 By Solution
9.3 By Technology
9.4 By Application
9.5 By End User
9.6 By Country
Chapter 10. MEA Market Size and Forecast
10.1 Overview
10.2 By Solution
10.3 By Technology
10.4 By Application
10.5 By End User
10.6 By Country
Chapter 11. Competitive Landscape
11.1 List of Players and Their Offerings
11.2 Competitive Benchmarking of Key Players
11.3 Strategic Developments in the Market
11.3.1 Mergers and Acquisitions
11.3.2 Product and Service Launches
11.3.3 Partnerships
11.3.4 Other Developments
Chapter 12. Company Profiles
12.1 Bio-Rad Laboratories Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Agilent Technologies Inc.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Quest Diagnostics Inc.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Danaher Corporation
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 QIAGEN N.V.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 F. Hoffmann-La Roche Ltd.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Eurofins Scientific SE
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 Pacific Biosciences of California Inc.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 GENEWIZ Inc.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Psomagen Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 BGI Tech Solutions Co. Ltd.
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.12 Oxford Nanopore Technologies Ltd.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 10X Genomics Inc.
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.13.3 Key Financial Summary
12.14 Eppendorf AG
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.14.3 Key Financial Summary
12.15 Thermo Fisher Scientific Inc.
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.15.3 Key Financial Summary
12.16 Illumina Inc.
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.16.3 Key Financial Summary
Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports
List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 COVID-19 IMPACT ANALYSIS ON DIFFERENT SECTORS
TABLE 5 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 6 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 7 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 8 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 9 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 10 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 11 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 12 GLOBAL GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 13 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2019)
TABLE 14 GLOBAL GENOMICS MARKET, BY REGION, $M (2020-2030)
TABLE 15 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 16 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 17 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 18 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 19 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 20 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 21 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 22 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 23 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 25 U.S. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 26 U.S. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 27 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 28 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 29 CANADA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 30 CANADA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 31 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 32 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 33 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 34 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 35 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 36 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 37 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 38 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 39 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 40 EUROPE GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 41 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 42 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 43 U.K. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 44 U.K. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 45 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 46 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 47 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 48 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 49 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 50 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 51 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 52 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 53 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 54 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 55 ITALY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 56 ITALY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 57 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 58 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 59 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 60 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 61 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 62 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 63 APAC GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 64 APAC GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 65 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 66 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 67 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 68 APAC GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 69 APAC GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 70 APAC GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 71 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 72 APAC GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 73 CHINA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 74 CHINA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 75 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 76 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 77 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 78 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 79 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 80 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 81 INDIA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 82 INDIA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 83 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 84 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 85 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 86 LATAM GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 87 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 88 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 89 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 90 LATAM GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 91 LATAM GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 92 LATAM GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 93 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 94 LATAM GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 95 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 96 MEA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 97 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 98 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 99 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 100 MEA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 101 MEA GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 102 MEA GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 103 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 104 MEA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 105 LIST OF PLAYERS AND THEIR OFFERINGS
TABLE 106 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 107 BIO-RAD LABORATORIES INC. - AT A GLANCE
TABLE 108 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
TABLE 109 AGILENT TECHNOLOGIES INC. - AT A GLANCE
TABLE 110 AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY
TABLE 111 QUEST DIAGNOSTICS INC. - AT A GLANCE
TABLE 112 QUEST DIAGNOSTICS INC. - KEY FINANCIAL SUMMARY
TABLE 113 DANAHER CORPORATION - AT A GLANCE
TABLE 114 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
TABLE 115 QIAGEN N.V. - AT A GLANCE
TABLE 116 QIAGEN N.V. - KEY FINANCIAL SUMMARY
TABLE 117 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
TABLE 118 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
TABLE 119 EUROFINS SCIENTIFIC SE - AT A GLANCE
TABLE 120 EUROFINS SCIENTIFIC SE - KEY FINANCIAL SUMMARY
TABLE 121 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - AT A GLANCE
TABLE 122 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - KEY FINANCIAL SUMMARY
TABLE 123 GENEWIZ INC. - AT A GLANCE
TABLE 124 PSOMAGEN INC. - AT A GLANCE
TABLE 125 BGI TECH SOLUTIONS CO. LTD. - AT A GLANCE
TABLE 126 OXFORD NANOPORE TECHNOLOGIES LTD. - AT A GLANCE
TABLE 127 10X GENOMICS INC. - AT A GLANCE
TABLE 128 10X GENOMICS INC. - KEY FINANCIAL SUMMARY
TABLE 129 EPPENDORF AG - AT A GLANCE
TABLE 130 EPPENDORF AG - KEY FINANCIAL SUMMARY
TABLE 131 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
TABLE 132 THERMO FISHER SCIENTIFIC INC.- KEY FINANCIAL SUMMARY
TABLE 133 ILLUMINA INC.- AT A GLANCE
TABLE 134 ILLUMINA INC.- KEY FINANCIAL SUMMARY
List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 GLOBAL GENOMICS MARKET SUMMARY
FIG 8 BARGAINING POWER OF BUYERS
FIG 9 BARGAINING POWER OF SUPPLIERS
FIG 10 INTENSITY OF RIVALRY
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 THREAT OF SUBSTITUTES
FIG 13 GLOBAL GENOMICS MARKET SNAPSHOT
FIG 14 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 15 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 16 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 17 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 18 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2030)
FIG 19 NORTH AMERICA GENOMICS MARKET SNAPSHOT
FIG 20 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 21 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 22 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 23 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 25 EUROPE GENOMICS MARKET SNAPSHOT
FIG 26 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 27 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 28 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 29 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 30 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 31 APAC GENOMICS MARKET SNAPSHOT
FIG 32 APAC GENOMICS MARKET, BY SOLUTION $M (2014-2030)
FIG 33 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 34 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 35 APAC GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 36 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 37 LATAM GENOMICS MARKET SNAPSHOT
FIG 38 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 39 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 40 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 41 LATAM GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 42 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 43 MEA GENOMICS MARKET SNAPSHOT
FIG 44 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 45 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 46 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 47 MEA GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 48 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 49 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 50 AGILENT TECHNOLOGIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 51 QUEST DIAGNOSTICS INC. - REVENUE SPLIT BY DIVISION (2019)
FIG 52 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 53 QIAGEN N.V. - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2019)
FIG 54 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 55 EUROFINS SCIENTIFIC SE - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 56 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - REVENUE SPLIT BY CATEGORY AND GEOGRAPHY (2019)
FIG 57 10X GENOMICS INC. - REVENUE SPLIT BY CATEGORY AND GEOGRAPHY (2019)
FIG 58 EPPENDORF AG - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 59 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 60 ILLUMINA INC. - REVENUE SPLIT BY PRODUCTS AND SERVICES AND GEOGRAPHY (2019)
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Solution
1.3.2 Market Segmentation by Technology
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.2 Primary Research
2.2.1 Split of Primary Research Information
2.2.2 Breakdown of Primary Research Respondents
2.2.2.1 By industry participant
2.2.2.2 By company type
2.2.3 Breakdown of Primary Research by Company and Designation
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 Data Triangulation
2.6 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Solution
4.1.1.1 Consumables
4.1.1.2 Instruments
4.1.1.3 Services
4.1.2 By Technology
4.1.2.1 PCR
4.1.2.2 Sequencing
4.1.2.3 Microarray
4.1.2.4 Others
4.1.3 By Application
4.1.3.1 Diagnostics
4.1.3.2 Drug discovery and development
4.1.3.3 Precision medicine
4.1.3.4 Agriculture and animal research
4.1.3.5 Others
4.1.4 By End User
4.1.4.1 Research centers and academic institutes
4.1.4.2 Hospitals and clinics
4.1.4.3 Pharmaceutical and biotechnology companies
4.1.4.4 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing number of acquisitions
4.2.1.2 Growing partnerships among market players
4.2.2 Drivers
4.2.2.1 Rising government support and initiatives
4.2.2.2 Reducing cost of sequencing services
4.2.2.3 Growing demand for personalized medicines
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Data privacy concerns
4.2.3.2 High data storage requirements
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Potential to cure previously incurable diseases
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Buyers
4.4.2 Bargaining Power of Suppliers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes
Chapter 5. Global Market Size and Forecast
5.1 By Solution
5.2 By Technology
5.3 By Application
5.4 By End User
5.5 By Region
Chapter 6. North America Market Size and Forecast
6.1 Overview
6.2 By Solution
6.3 By Technology
6.4 By Application
6.5 By End User
6.6 By Country
6.6.1 U.S. Market Size and Forecast
6.6.1.1 By solution
6.6.1.2 By technology
6.6.2 Canada Market Size and Forecast
6.6.2.1 By solution
6.6.2.2 By technology
Chapter 7. Europe Market Size and Forecast
7.1 Overview
7.2 By Solution
7.3 By Technology
7.4 By Application
7.5 By End User
7.6 By Country
7.6.1 U.K. Market Size and Forecast
7.6.1.1 By solution
7.6.1.2 By technology
7.6.2 Germany Market Size and Forecast
7.6.2.1 By solution
7.6.2.2 By technology
7.6.3 France Market Size and Forecast
7.6.3.1 By solution
7.6.3.2 By technology
7.6.4 Italy Market Size and Forecast
7.6.4.1 By solution
7.6.4.2 By technology
7.6.5 Spain Market Size and Forecast
7.6.5.1 By solution
7.6.5.2 By technology
Chapter 8. APAC Market Size and Forecast
8.1 Overview
8.2 By Solution
8.3 By Technology
8.4 By Application
8.5 By End User
8.6 By Country
8.6.1 China Market Size and Forecast
8.6.1.1 By solution
8.6.1.2 By technology
8.6.2 Japan Market Size and Forecast
8.6.2.1 By solution
8.6.2.2 By technology
8.6.3 India Market Size and Forecast
8.6.3.1 By solution
8.6.3.2 By technology
Chapter 9. LATAM Market Size and Forecast
9.1 Overview
9.2 By Solution
9.3 By Technology
9.4 By Application
9.5 By End User
9.6 By Country
Chapter 10. MEA Market Size and Forecast
10.1 Overview
10.2 By Solution
10.3 By Technology
10.4 By Application
10.5 By End User
10.6 By Country
Chapter 11. Competitive Landscape
11.1 List of Players and Their Offerings
11.2 Competitive Benchmarking of Key Players
11.3 Strategic Developments in the Market
11.3.1 Mergers and Acquisitions
11.3.2 Product and Service Launches
11.3.3 Partnerships
11.3.4 Other Developments
Chapter 12. Company Profiles
12.1 Bio-Rad Laboratories Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Agilent Technologies Inc.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Quest Diagnostics Inc.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Danaher Corporation
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 QIAGEN N.V.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 F. Hoffmann-La Roche Ltd.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Eurofins Scientific SE
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 Pacific Biosciences of California Inc.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 GENEWIZ Inc.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Psomagen Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 BGI Tech Solutions Co. Ltd.
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.12 Oxford Nanopore Technologies Ltd.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 10X Genomics Inc.
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.13.3 Key Financial Summary
12.14 Eppendorf AG
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.14.3 Key Financial Summary
12.15 Thermo Fisher Scientific Inc.
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.15.3 Key Financial Summary
12.16 Illumina Inc.
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.16.3 Key Financial Summary
Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports
List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 COVID-19 IMPACT ANALYSIS ON DIFFERENT SECTORS
TABLE 5 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 6 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 7 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 8 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 9 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 10 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 11 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 12 GLOBAL GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 13 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2019)
TABLE 14 GLOBAL GENOMICS MARKET, BY REGION, $M (2020-2030)
TABLE 15 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 16 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 17 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 18 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 19 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 20 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 21 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 22 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 23 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 25 U.S. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 26 U.S. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 27 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 28 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 29 CANADA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 30 CANADA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 31 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 32 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 33 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 34 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 35 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 36 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 37 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 38 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 39 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 40 EUROPE GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 41 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 42 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 43 U.K. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 44 U.K. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 45 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 46 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 47 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 48 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 49 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 50 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 51 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 52 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 53 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 54 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 55 ITALY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 56 ITALY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 57 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 58 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 59 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 60 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 61 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 62 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 63 APAC GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 64 APAC GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 65 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 66 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 67 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 68 APAC GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 69 APAC GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 70 APAC GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 71 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 72 APAC GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 73 CHINA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 74 CHINA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 75 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 76 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 77 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 78 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 79 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 80 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 81 INDIA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 82 INDIA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 83 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 84 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 85 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 86 LATAM GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 87 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 88 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 89 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 90 LATAM GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 91 LATAM GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 92 LATAM GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 93 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 94 LATAM GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 95 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
TABLE 96 MEA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
TABLE 97 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 98 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 99 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
TABLE 100 MEA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
TABLE 101 MEA GENOMICS MARKET, BY END USER, $M (2014-2019)
TABLE 102 MEA GENOMICS MARKET, BY END USER, $M (2020-2030)
TABLE 103 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
TABLE 104 MEA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
TABLE 105 LIST OF PLAYERS AND THEIR OFFERINGS
TABLE 106 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 107 BIO-RAD LABORATORIES INC. - AT A GLANCE
TABLE 108 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
TABLE 109 AGILENT TECHNOLOGIES INC. - AT A GLANCE
TABLE 110 AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY
TABLE 111 QUEST DIAGNOSTICS INC. - AT A GLANCE
TABLE 112 QUEST DIAGNOSTICS INC. - KEY FINANCIAL SUMMARY
TABLE 113 DANAHER CORPORATION - AT A GLANCE
TABLE 114 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
TABLE 115 QIAGEN N.V. - AT A GLANCE
TABLE 116 QIAGEN N.V. - KEY FINANCIAL SUMMARY
TABLE 117 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
TABLE 118 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
TABLE 119 EUROFINS SCIENTIFIC SE - AT A GLANCE
TABLE 120 EUROFINS SCIENTIFIC SE - KEY FINANCIAL SUMMARY
TABLE 121 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - AT A GLANCE
TABLE 122 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - KEY FINANCIAL SUMMARY
TABLE 123 GENEWIZ INC. - AT A GLANCE
TABLE 124 PSOMAGEN INC. - AT A GLANCE
TABLE 125 BGI TECH SOLUTIONS CO. LTD. - AT A GLANCE
TABLE 126 OXFORD NANOPORE TECHNOLOGIES LTD. - AT A GLANCE
TABLE 127 10X GENOMICS INC. - AT A GLANCE
TABLE 128 10X GENOMICS INC. - KEY FINANCIAL SUMMARY
TABLE 129 EPPENDORF AG - AT A GLANCE
TABLE 130 EPPENDORF AG - KEY FINANCIAL SUMMARY
TABLE 131 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
TABLE 132 THERMO FISHER SCIENTIFIC INC.- KEY FINANCIAL SUMMARY
TABLE 133 ILLUMINA INC.- AT A GLANCE
TABLE 134 ILLUMINA INC.- KEY FINANCIAL SUMMARY
List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 GLOBAL GENOMICS MARKET SUMMARY
FIG 8 BARGAINING POWER OF BUYERS
FIG 9 BARGAINING POWER OF SUPPLIERS
FIG 10 INTENSITY OF RIVALRY
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 THREAT OF SUBSTITUTES
FIG 13 GLOBAL GENOMICS MARKET SNAPSHOT
FIG 14 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 15 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 16 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 17 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 18 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2030)
FIG 19 NORTH AMERICA GENOMICS MARKET SNAPSHOT
FIG 20 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 21 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 22 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 23 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 25 EUROPE GENOMICS MARKET SNAPSHOT
FIG 26 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 27 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 28 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 29 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 30 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 31 APAC GENOMICS MARKET SNAPSHOT
FIG 32 APAC GENOMICS MARKET, BY SOLUTION $M (2014-2030)
FIG 33 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 34 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 35 APAC GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 36 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 37 LATAM GENOMICS MARKET SNAPSHOT
FIG 38 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 39 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 40 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 41 LATAM GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 42 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 43 MEA GENOMICS MARKET SNAPSHOT
FIG 44 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
FIG 45 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 46 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
FIG 47 MEA GENOMICS MARKET, BY END USER, $M (2014-2030)
FIG 48 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
FIG 49 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 50 AGILENT TECHNOLOGIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 51 QUEST DIAGNOSTICS INC. - REVENUE SPLIT BY DIVISION (2019)
FIG 52 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 53 QIAGEN N.V. - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2019)
FIG 54 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 55 EUROFINS SCIENTIFIC SE - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 56 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - REVENUE SPLIT BY CATEGORY AND GEOGRAPHY (2019)
FIG 57 10X GENOMICS INC. - REVENUE SPLIT BY CATEGORY AND GEOGRAPHY (2019)
FIG 58 EPPENDORF AG - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 59 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 60 ILLUMINA INC. - REVENUE SPLIT BY PRODUCTS AND SERVICES AND GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
3 of 4
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- Quest Diagnostics Inc.
- Danaher Corporation
- QIAGEN N.V.
- F. Hoffmann-La Roche Ltd.
- Eurofins Scientific SE
- Pacific Biosciences of California Inc.
- GENEWIZ Inc.
- Psomagen Inc.
- BGI Tech Solutions Co. Ltd.
- Oxford Nanopore Technologies Ltd.
- 10X Genomics Inc.
- Eppendorf AG
- Thermo Fisher Scientific Inc.
- Illumina Inc.
Note: Product cover images may vary from those shown
4 of 4
LOADING...
